Guidance

Screening for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome: non-invasive prenatal testing (NIPT)

Operational guidance to support the offer of NIPT.

Applies to England

Documents

Details

For health care professionals offering non-invasive prenatal testing (NIPT) screening for Down’s syndrome (T21), Edwards’ syndrome (T18) and Patau’s syndrome (T13).

Includes information on:

  • eligibility for NIPT within NHS FASP
  • laboratory requirements for NIPT
  • blood sampling and transport
  • reporting NIPT results
Published 26 April 2021
Last updated 6 October 2023 + show all updates
  1. 2.2 North Thames GLH (Health Service Laboratory (HSL)) blood sampling and transport value has changed.

  2. Added lower chance result letter templates.

  3. Added information about screening safety incidents (section 9).

  4. First published.